Edge Wealth Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Edge Wealth Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-34	Closed	-$1K	–	708
2019 Q4	$1K	Hold	34	–	–	﹤0.01%	588
2019 Q3	$1K	Buy	+34	New	+$18	﹤0.01%	591
2019 Q2	–	Sell	-34	Closed	–	–	654
2019 Q1	$0	Buy	+34	New	+$16	﹤0.01%	643
2017 Q2	–	Sell	-34	Closed	-$1K	–	589
2017 Q1	$1K	Hold	34	–	–	﹤0.01%	512
2016 Q4	$1K	Buy	+34	New	+$12	﹤0.01%	485
2015 Q3	–	Sell	-34	Closed	–	–	495
2015 Q2	$0	Buy	+34	New	+$24	﹤0.01%	481
2013 Q4	–	Sell	-34	Closed	–	–	396
2013 Q3	$0	Hold	34	–	–	﹤0.01%	389
2013 Q2	$0	Buy	+34	New	+$60	﹤0.01%	339

Edge Wealth Management's GCVRZ Position: Q1 2020 in Review

Edge Wealth Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 34 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in GCVRZ in Q2 2013 and held it in 8 quarters. The position peaked at $1K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Edge Wealth Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Edge Wealth Management sold 34 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1K.
Edge Wealth Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 8 quarters.
Edge Wealth Management's Sanofi Contingent Value Rights position peaked at $1K in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Edge Wealth Management's 13F filing for Q1 2020, filed 20 Apr 2020.